Emerging Challenges in Laboratory Medicine
The course will provide an overview of different models to set performance specifications in laboratory medicine; 1) based on clinical outcome, on 2) biological variation, and 3) state of the art. In addition, it will address the total error concept, and performance specifications in external quality assessment schemes and in the extra-analytical phases.
The availability of highly sensitive troponin assays (hsTn) allows the safe clinical application of international recommendations and the introduction of fast-track protocols for the definition of AMI. However, hsTn assays have not always been welcomed by clinicians, claiming an increase in false-positive results. To guide interpretation of results, laboratory specialists need to get involved in communicating with clinicians through education, test interpretation and internal audits of test usage and patient outcomes.
A recording of a plenary presentation by professor Mauro Panteghini, recorded at 4th Joint EFLM-UEMS Congress: Warsaw, Poland, 21–24 September, 2016
Presenter: Arend Bökenkamp (Department of Pediatric Nephrology, VU University Medical Center, Amsterdam, Netherlands)
The presentation reviews the characteristics of cystatin C from a clinical point of view, focusing on its use in children.
presented by: prof. Dennis Hesselink, Erasmus MC, University Medical Center Rotterdam, Department of Internal Medicine, Division of Nephrology and Kidney Transplantation,
Rotterdam, the Netherlands
recorded at the 4th Joint EFLM-UEMS Congress “Laboratory Medicine at the Clinical Interface”, Warsaw, Poland, 21th–24th September, 2016